Erik Fouts

Erik Fouts serves as the Senior Vice President and Head of Technology Development at CRISPR Therapeutics. Prior experience includes roles at BioMarin Pharmaceutical Inc. where Erik held the positions of Vice President for Technical Operations Program and Portfolio Management, Vice President and Site Head for Novato Operations, and Executive Director of Process Sciences.